Back to search

Norway· NO-ID_051DD5F4-2742-4DD5-ADA4-A1D1A63A5C49

Tigecycline accord

A tigecycline product containing tigecycline, registered in Norway by Accord. The same ATC class is registered in 17 of our 19 countries.

ATC J01AA12

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedTigecycline accordATCJ01AA12REGISTER NO.NO-ID_051DD5F4-2742-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Tigecycline is registered in 17 of 19 countries.

Countries holding a registration under ATC J01AA12 (tigecycline), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 9 of them publish a price we can compare per daily dose

Tigecycline · ATC J01AA12

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tigecycline costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Tigecycline · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • FI Finland$3.05
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Tigecycline
Manufacturer
Accord
Country
Norway (NO)
ATC code
J01AA12
ATC class
Tigecycline
Defined daily dose
0.1 g, P
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_051DD5F4-2742-4DD5-ADA4-A1D1A63A5C49
  • no_varenummer
    348009
    10 x 50
  • gtin
    3400955072690

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

65 interactions on record for tigecycline.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tigecycline · interactions on record

65 records

  • 3 severe
  • 13 moderate
  • 24 info

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe
  • Sodium picosulfateA06AB08moderate

25 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tigecycline in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tigecycline products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Tigecyclin Aptapharma, Tigecyclin Hikma
  • Bulgaria · Тигециклин Аптафарма, Тигециклин Ромфарм
  • Cyprus · Tigecycline Aptapharma, Tigecycline Sapiens
  • Czechia · Tigecycline Aptapharma, Tigecycline Mylan
  • Germany · Tigecyclin Amarox, Tigecyclin Carinopharm
  • Denmark · Tigecycline Eql Pharma
  • Estonia · Tigecycline Inteli, Tigecycline Norameda
  • Spain · Tigeciclina Cipla, Tigeciclina Hikma
  • Finland · Tigecycline Eql Pharma, Tigecycline Norameda
  • France · Tigecycline Amarox, Tigecycline Hikma
  • United Kingdom (Northern Ireland) · Tigecycline Aft Pharma Uk, Tigecycline Amarox
  • Greece · Digazor, Tigecycline Anfarm
  • Croatia · Tigeciklin Aptapharma, Tigeciklin Galenika
  • Hungary · Tigeciklin Galenika, Tigeciklin Noridem
  • Ireland · Tigecycline Noridem Enterprises
  • Iceland · Tigecycline Accord, Tygacil
  • Italy · Tigeciclina Amarox, Tigeciclina Cipla
  • Liechtenstein · Tigecycline Accord, Tygacil
  • Lithuania · Tigecycline Inteli, Tigecycline Norameda
  • Latvia · Tigecycline Inteli, Tigecycline Norameda
  • Malta · Tigecycline Anfarm, Tigecycline Aptapharma
  • Netherlands · Tigecycline Amarox, Tigecycline Hikma
  • Poland · Tigecycline Aptapharma, Tigecycline Norameda
  • Portugal · Tigeciclina Cipla, Tigeciclina Hikma
  • Romania · Tigeciclină Aptapharma, Tigeciclina Atb
  • Sweden · Tigecycline Eql Pharma, Tigecycline Viatris
  • Slovenia · Tigeciklin Aptapharma, Tigeciklin Diagonalis
  • Slovakia · Tigecycline Aptapharma, Tigecycline Noridem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/db4a4b56-b85c-4fda-8ae9-5cecc9e00aea
GET /v1/drugs/db4a4b56-b85c-4fda-8ae9-5cecc9e00aea?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pulver til infusjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Tigesyklin",
  "merkevare_id": "ID_051DD5F4-2742-4DD5-ADA4-A1D1A63A5C49",
  "name_form_strength": "Tigecycline accord pulv til inf væske oppl 50 mg",
  "prescription_group": "C"
}

See everything about tigecycline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.